London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The market cap of this company is £115m and trades 1.5m shares a day. If a shorter is on this forum with the aim of influencing the share price he/ she is waisting time. Same goes for anyone pumping the stock.
The only reason this stock has been declining, and every other stock of a company developing new biotherapeutics, is that large holders have been selling. Maybe DDDD is gonna fold and maybe its going to the moon but there's no sense letting this nonsense ruin your day--it's a whisper in the wind and has no impact.
The shorter's job is the same as ours on the flip side, to create doubt rather than belief, but they're going to need to "borrow" a hell of a lot more than around 8 - 900,000 shares to have any impact whatsoever as is being demonstrated now and was demonstrated by the previous short incumbent with quite a few more shares. I do think we've had quite an impact by setting our limit sells high enough to prevent the access shorter's had previously.
I think this shorter’s job is to follow the stochastic indicator until the anticipated news breaks
Well I cannot afford to buy anymore but console myself with the probability that they will not leave disclosure of trial results right to the end of the year. So I am expecting asthma or pancreatic progress some time in November so not too long to wait.
Bought more this morning,will continue to buy on any red days. Can’t stay silent forever.
Didn’t mean to be rude just wondered why someone paying for a broker took advice from someone on a bb.
Be well stay long.
He’s no stranger, he’s Sanji, buy far the most knowledgeable person here. I believe that I can make my money move quicker elsewhere for the next 6 weeks.
It’s a risk that I believe is worth taking. No need to be staggered
Picked up just under 10k in the mid 60s today,this isn’t performing like a share being shorted so happy to add.
I’m actually staggered,someone sold shares on the advice of a stranger on a bb that admitted he hasn’t a clue.
What the actual fluff.
You’ve just convinced me to sell up for the time being. Just sold 9300 shares @ 62.70. It’s a bit of a gamble but I’m going to come back in December. I just feel that the guys running the short will be persistent and will dice it down to low 50’s. If it does I’ll buy back in then.
GLA. See you in a few months
I don't think anything trial related will boost the price unless the 0518 Keytruda data is mind blowing. Everything is all a bit piecemeal but the whole is so much greater than the parts.
I think they must have triggered a small milestone payment, say £5m, if the vaccine program has gone from looking for LBP candidates to a pre clinical stage where 1 or more LBPs has been identified. As I understand it the LBP candidate(s) were due to be handed over to Merck for them to take over the trial research.
The Blautix update could be interesting.
If you are planning to stay invested I would get a good sleeping bag.
Fair enough. Thx for replying
I'm sorry I haven't a clue.
Sanji. Where do you see this share going in the next few weeks ?
https://twitter.com/neverton_29/status/1452931252009541632?s=20 yes around 10.15 5 blocks of £25K
Rubbish, someone has dumped well over £100k worth this morning and not a short seller.
Just spoke to my broker and the there are 27000 shares bid against 10,000 offered. It looks like investors are taking advantage of the cheap SP that has been created by the short selling. No one other than the shorter’s are selling